T-cell masthead image

Publications

Publication

Vaccine – Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection

Publication

Frontiers in Drug Discovery – HyBryte™ use in early-stage cutaneous T-cell lymphoma

Publication

Journal of the American Medical Association Dermatology – Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Publication

Dr. Schaber’s Interview with The Price of Business

Publication

Frontiers in Immunity CoVaccine HT™ Publication

  • External Link
COVID-19: Haun, B.K., Lai, C.Y., Williams, C.A., Wong, T.A.S., Lieberman, M.M., Pessaint, L., Andersen, H., Lehrer, A.T. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. 2020.
Publication

Article in Drug Target Review

In this article in Drug Target Review, Drs. Donini, Schaber, and Straube discuss innate immunity.
Publication

Dr. Oreola Donini’s Interview with Nature

In this interview, Dr. Oreola Donini, Senior Vice President and Chief Scientific Officer, discusses innate immunity and development of Innate Defense Regulator technology with Nature.
Publication

Soligenix Discusses Ricin Toxin Vaccine

Dr. Oreola Donini, Senior Vice President and Chief Scientific Officer, discusses the Company's ricin toxin vaccine with ROI-NJ.
Publication

Biotechnology Reports – Dusquetide: Reduction in Oral Mucositis associated with Enduring Ancillary Benefits in Tumor Resolution and Decreased Mortality in Head and Neck Cancer Patients

Read the Publication
Publication

BioWorld Today Ricin Toxin Program Review

In a recent article in BioWorld Today, the Soligenix ricin toxin vaccine program was reviewed, including comments from Dr. Oreola Donini, Chief Scientific Officer of Soligenix.